132 related articles for article (PubMed ID: 22158876)
21. Insertion of type O-conserved neutralizing epitope into the foot-and-mouth disease virus type Asia1 VP1 G-H loop: effect on viral replication and neutralization phenotype.
Wang H; Xue M; Yang D; Zhou G; Wu D; Yu L
J Gen Virol; 2012 Jul; 93(Pt 7):1442-1448. PubMed ID: 22513388
[TBL] [Abstract][Full Text] [Related]
22. Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response.
Moraes MP; Segundo FD; Dias CC; Pena L; Grubman MJ
Vaccine; 2011 Nov; 29(51):9431-40. PubMed ID: 22027486
[TBL] [Abstract][Full Text] [Related]
23. A recombinant porcine circovirus type 2 expressing the VP1 epitope of the type O foot-and-mouth disease virus is infectious and induce both PCV2 and VP1 epitope antibodies.
Huang L; Zhang F; Tang Q; Wei Y; Wu H; Guo L; Fu Y; Liu C
Appl Microbiol Biotechnol; 2014 Nov; 98(22):9339-50. PubMed ID: 25117547
[TBL] [Abstract][Full Text] [Related]
24. A foot-and-mouth disease SAT2 vaccine protects swine against experimental challenge with a homologous virus strain, irrespective of mild pathogenicity in this species.
Mouton L; Dekker A; Bleijenberg M; Blanchet M; Coco-Martin J; Hudelet P; Goutebroze S
Vaccine; 2018 Apr; 36(15):2020-2024. PubMed ID: 29510916
[TBL] [Abstract][Full Text] [Related]
25. Characterization of Epitope-Specific Anti-Respiratory Syncytial Virus (Anti-RSV) Antibody Responses after Natural Infection and after Vaccination with Formalin-Inactivated RSV.
Widjaja I; Wicht O; Luytjes W; Leenhouts K; Rottier PJM; van Kuppeveld FJM; Haijema BJ; de Haan CAM
J Virol; 2016 Jul; 90(13):5965-5977. PubMed ID: 27099320
[TBL] [Abstract][Full Text] [Related]
26. Production and application of recombinant antibodies to foot-and-mouth disease virus non-structural protein 3ABC.
Foord AJ; Muller JD; Yu M; Wang LF; Heine HG
J Immunol Methods; 2007 Apr; 321(1-2):142-51. PubMed ID: 17328909
[TBL] [Abstract][Full Text] [Related]
27. Identification of a conserved linear neutralizing epitope recognized by monoclonal antibody 9A9 against serotype A foot-and-mouth disease virus.
Liang W; Zhou G; Liu W; Yang B; Li C; Wang H; Yang D; Ma W; Yu L
Arch Virol; 2016 Oct; 161(10):2705-16. PubMed ID: 27422396
[TBL] [Abstract][Full Text] [Related]
28. Custom-engineered chimeric foot-and-mouth disease vaccine elicits protective immune responses in pigs.
Blignaut B; Visser N; Theron J; Rieder E; Maree FF
J Gen Virol; 2011 Apr; 92(Pt 4):849-59. PubMed ID: 21177923
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of cross-protection against three topotypes of serotype O foot-and-mouth disease virus in pigs vaccinated with multi-epitope protein vaccine incorporated with poly(I:C).
Cao Y; Lu Z; Li D; Fan P; Sun P; Bao H; Fu Y; Li P; Bai X; Chen Y; Xie B; Liu Z
Vet Microbiol; 2014 Jan; 168(2-4):294-301. PubMed ID: 24345411
[TBL] [Abstract][Full Text] [Related]
30. Structures of Foot-and-mouth Disease Virus with neutralizing antibodies derived from recovered natural host reveal a mechanism for cross-serotype neutralization.
He Y; Li K; Cao Y; Sun Z; Li P; Bao H; Wang S; Zhu G; Bai X; Sun P; Liu X; Yang C; Liu Z; Lu Z; Rao Z; Lou Z
PLoS Pathog; 2021 Apr; 17(4):e1009507. PubMed ID: 33909694
[TBL] [Abstract][Full Text] [Related]
31. Multiple efficacy studies of an adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle using homologous challenge.
Schutta C; Barrera J; Pisano M; Zsak L; Grubman MJ; Mayr GA; Moraes MP; Kamicker BJ; Brake DA; Ettyreddy D; Brough DE; Butman BT; Neilan JG
Vaccine; 2016 Jun; 34(27):3214-3220. PubMed ID: 26707216
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of novel inactivated vaccines for the SAT 1, SAT 2 and SAT 3 serotypes of foot-and-mouth disease in pigs.
Jo HE; You SH; Choi JH; Ko MK; Shin SH; Song J; Jo H; Lee MJ; Kim SM; Kim B; Park JH
Virol J; 2019 Dec; 16(1):156. PubMed ID: 31842907
[TBL] [Abstract][Full Text] [Related]
33. The VP1 G-H loop hypervariable epitope contributes to protective immunity against Foot and Mouth Disease Virus in swine.
Fernandez-Sainz I; Gavitt TD; Koster M; Ramirez-Medina E; Rodriguez YY; Wu P; Silbart LK; de Los Santos T; Szczepanek SM
Vaccine; 2019 Jun; 37(26):3435-3442. PubMed ID: 31085001
[TBL] [Abstract][Full Text] [Related]
34. Immune potential of a novel multiple-epitope vaccine to FMDV type Asia 1 in guinea pigs and sheep.
Shao JJ; Wang JF; Chang HY; Liu JX
Virol Sin; 2011 Jun; 26(3):190-7. PubMed ID: 21667339
[TBL] [Abstract][Full Text] [Related]
35. Identification of a conserved linear epitope on the VP1 protein of serotype O foot-and-mouth disease virus by neutralising monoclonal antibody 8E8.
Yang D; Zhang C; Zhao L; Zhou G; Wang H; Yu L
Virus Res; 2011 Jan; 155(1):291-9. PubMed ID: 20974198
[TBL] [Abstract][Full Text] [Related]
36. Adenovirus-vectored type Asia1 foot-and-mouth disease virus (FMDV) capsid proteins as a vehicle to display a conserved, neutralising epitope of type O FMDV.
Chai Z; Wang H; Zhou G; Yang D; Wang J; Yu L
J Virol Methods; 2013 Mar; 188(1-2):175-82. PubMed ID: 22981982
[TBL] [Abstract][Full Text] [Related]
37. The detection of long-lasting memory foot-and-mouth disease (FMD) virus serotype O-specific CD4
Mitoma S; Carr BV; Harvey Y; Moffat K; Sekiguchi S; Charleston B; Norimine J; Seago J
Immunology; 2021 Oct; 164(2):266-278. PubMed ID: 34003490
[TBL] [Abstract][Full Text] [Related]
38. Comparison of immune responses against foot-and-mouth disease virus induced by fusion proteins using the swine IgG heavy chain constant region or beta-galactosidase as a carrier of immunogenic epitopes.
Li G; Chen W; Yan W; Zhao K; Liu M; Zhang J; Fei L; Xu Q; Sheng Z; Lu Y; Zheng Z
Virology; 2004 Oct; 328(2):274-81. PubMed ID: 15464847
[TBL] [Abstract][Full Text] [Related]
39. Co-expression of the Bcl-xL antiapoptotic protein enhances the induction of Th1-like immune responses in mice immunized with DNA vaccines encoding FMDV B and T cell epitopes.
Gülçe İz S; Döşkaya M; Borrego B; Rodriguez F; Gürüz Y; Gürhan ID
Vet Res Commun; 2013 Sep; 37(3):187-96. PubMed ID: 23483312
[TBL] [Abstract][Full Text] [Related]
40. Duration of protection and humoral immunity induced by an adenovirus-vectored subunit vaccine for foot-and-mouth disease (FMD) in Holstein steers.
Sitt T; Kenney M; Barrera J; Pandya M; Eckstrom K; Warner M; Pacheco JM; LaRocco M; Palarea-Albaladejo J; Brake D; Rieder E; Arzt J; Barlow JW; Golde WT
Vaccine; 2019 Sep; 37(42):6221-6231. PubMed ID: 31493951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
